---
title: "Jingtai Holdings (2228.HK) FY2025 Quick Earnings Review: Revenue +55%, Turns Loss into Profit"
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/39510861.md"
description: "📊 Jingtai Holdings (2228.HK) FY2025 Earnings Quick Review Release Date: 2026-03-25 Data Source: HKEX Announcement, Company Report 🔑 Key Highlights Indicator FY2025 YoY Interpretation Revenue ¥803 million +55%+ Rapid growth Net Profit ¥135 million Turned profitable Profit inflection point Net Profit Margin 16.8% - Healthy level 📈 Business Structure Dual-engine drive: - Drug Discovery Solutions: ¥538 million (67%) — Cash cow business - ..."
datetime: "2026-03-25T11:48:22.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39510861.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39510861.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39510861.md)
author: "[老板的老板 AI Exec](https://longbridge.com/en/profiles/123.md)"
---

# Jingtai Holdings (2228.HK) FY2025 Quick Earnings Review: Revenue +55%, Turns Loss into Profit

# 📊 Gentron Holdings (2228.HK) FY2025 Earnings Quick Review

**Release Date:** 2026-03-25  
**Data Source:** HKEX Announcements, Company Financial Reports

* * *

## 🔑 Key Highlights

Metric

FY2025

YoY

Interpretation

**Revenue**

¥803 million

+55%+

Rapid growth

**Net Profit**

¥135 million

Turned to profit

**Profit inflection point**

**Net Profit Margin**

16.8%

\-

Healthy level

* * *

## 📈 Business Structure

**Dual-engine driven:** - **Drug Discovery Solutions**: ¥538 million (67%) — Cash cow business - **AI4S Smart Solutions**: ¥265 million (33%) — Growth engine

**Strategic Transformation:** AI4S business evolved from a single solution → a cross-industry enabling platform (Biopharma + New Materials + Chemical)

* * *

## 🎯 Strategic Highlights

### 1\. Multi-Agent System

-   Supports end-to-end R&D workflow
-   Reduces manual intervention, improves efficiency
-   Enhances competitiveness in the AI for Science field

### 2\. Cross-industry Expansion

-   **Biopharma**: Traditional strength, continuous deepening
-   **New Materials/Chemical**: Large market space, less competition
-   **Top-tier Endorsement**: Successfully deployed a BASF advanced automation workstation in 2025

* * *

**Data Source:** HKEX Announcements, Company Financial Reports  
**Disclaimer:** This analysis is for reference only and does not constitute investment advice.

### Related Stocks

- [BAS.DE](https://longbridge.com/en/quote/BAS.DE.md)
- [02228.HK](https://longbridge.com/en/quote/02228.HK.md)

## Comments (19)

- **Alexx · 2026-03-25T12:07:05.000Z**: Does Longbridge not have live streams anymore?
- **大象上的蚂蚁 · 2026-03-25T12:04:46.000Z**: Not much to say, Doc, you need to take care of your health. You've been coughing non-stop. We're all counting on you.
  - **老板的老板 AI Exec** (2026-03-25T13:43:20.000Z): Dr. Wen has been coughing for a while. It's too taxing on the body. Starting a business is tough.
- **年轻人不讲武德 · 2026-03-25T11:57:49.000Z**: Add positions tomorrow and go all in
- **周树人的交易员 · 2026-03-25T11:50:42.000Z · 👍 1**: Boss, is there any more information about this?
  - **老板的老板 AI Exec** (2026-03-25T11:52:03.000Z): This.......just be patient. 😂
  - **周树人的交易员** (2026-03-25T11:52:38.000Z): Alright 😂, then I'll continue listening to the brokerage firm's questions.
  - **周树人的交易员** (2026-03-25T11:54:49.000Z): Hahaha, drawing a pie in the sky for CITIC
- **老板的老板 AI Exec · 2026-03-25T11:49:17.000Z · 👍 2**: This is a small step for Jason...
  - **wolf-001** (2026-03-25T12:24:04.000Z): jason 表现不错